Cite
Elsheikh B, Severyn S, Zhao S, et al. Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy. Front Neurol. 2021;12:650532doi: 10.3389/fneur.2021.650532.
Elsheikh, B., Severyn, S., Zhao, S., Kline, D., Linsenmayer, M., Kelly, K., Tellez, M., Bartlett, A., Heintzman, S., Reynolds, J., Sterling, G., Weaver, T., Rajneesh, K., Kolb, S. J., & Arnold, W. D. (2021). Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy. Frontiers in neurology, 12650532. https://doi.org/10.3389/fneur.2021.650532
Elsheikh, Bakri, et al. "Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy." Frontiers in neurology vol. 12 (2021): 650532. doi: https://doi.org/10.3389/fneur.2021.650532
Elsheikh B, Severyn S, Zhao S, Kline D, Linsenmayer M, Kelly K, Tellez M, Bartlett A, Heintzman S, Reynolds J, Sterling G, Weaver T, Rajneesh K, Kolb SJ, Arnold WD. Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy. Front Neurol. 2021 Apr 16;12:650532. doi: 10.3389/fneur.2021.650532. eCollection 2021. PMID: 33935949; PMCID: PMC8085528.
Copy
Download .nbib